These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20860579)

  • 1. Bayesian and frequentist models: legitimate choices for different purposes of clinical research.
    Berger Z
    J Eval Clin Pract; 2010 Dec; 16(6):1045-7. PubMed ID: 20860579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian perspectives for epidemiological research. II. Regression analysis.
    Greenland S
    Int J Epidemiol; 2007 Feb; 36(1):195-202. PubMed ID: 17329317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian versus Frequentist statistical modeling: a debate for hit selection from HTS campaigns.
    Cloutier LM; Sirois S
    Drug Discov Today; 2008 Jun; 13(11-12):536-42. PubMed ID: 18549981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequentist evaluation of group sequential clinical trial designs.
    Emerson SS; Kittelson JM; Gillen DL
    Stat Med; 2007 Dec; 26(28):5047-80. PubMed ID: 17573678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequentist versus Bayesian approaches to multiple testing.
    Sjölander A; Vansteelandt S
    Eur J Epidemiol; 2019 Sep; 34(9):809-821. PubMed ID: 31087218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian perspectives for epidemiological research: I. Foundations and basic methods.
    Greenland S
    Int J Epidemiol; 2006 Jun; 35(3):765-75. PubMed ID: 16446352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The choice of sample size: a mixed Bayesian / frequentist approach.
    Pezeshk H; Nematollahi N; Maroufy V; Gittins J
    Stat Methods Med Res; 2009 Apr; 18(2):183-94. PubMed ID: 18445695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian perspectives for epidemiologic research: III. Bias analysis via missing-data methods.
    Greenland S
    Int J Epidemiol; 2009 Dec; 38(6):1662-73. PubMed ID: 19744933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian interpretation and analysis of research results.
    Greenland S
    Semin Hematol; 2008 Jul; 45(3):141-9. PubMed ID: 18582620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of underlying risk as a source of heterogeneity in meta-analyses: a simulation study of Bayesian and frequentist implementations of three models.
    Dohoo I; Stryhn H; Sanchez J
    Prev Vet Med; 2007 Sep; 81(1-3):38-55. PubMed ID: 17477995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Bayesian predictive strategy for an adaptive two-stage design in phase II clinical trials.
    Sambucini V
    Stat Med; 2010 Jun; 29(13):1430-42. PubMed ID: 20099246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
    Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
    J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian nonparametric hierarchical modeling.
    Dunson DB
    Biom J; 2009 Apr; 51(2):273-84. PubMed ID: 19358217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seven items were identified for inclusion when reporting a Bayesian analysis of a clinical study.
    Sung L; Hayden J; Greenberg ML; Koren G; Feldman BM; Tomlinson GA
    J Clin Epidemiol; 2005 Mar; 58(3):261-8. PubMed ID: 15718115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian semi-parametric ROC analysis.
    Erkanli A; Sung M; Costello EJ; Angold A
    Stat Med; 2006 Nov; 25(22):3905-28. PubMed ID: 16416403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bayesian statistics in medicine -- part II: main applications and inference].
    Montomoli C; Nichelatti M
    G Ital Nefrol; 2008; 25(4):422-31. PubMed ID: 18663689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multilevel modelling of medical data.
    Goldstein H; Browne W; Rasbash J
    Stat Med; 2002 Nov; 21(21):3291-315. PubMed ID: 12375305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Bayesian analysis of mixture structural equation models with non-ignorable missing responses and covariates.
    Cai JH; Song XY; Hser YI
    Stat Med; 2010 Aug; 29(18):1861-74. PubMed ID: 20680980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A false-discovery-rate-based loss framework for selection of interactions.
    Chen W; Ghosh D; Raghunathan TE; Sargent DJ
    Stat Med; 2008 May; 27(11):2004-21. PubMed ID: 17979139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.